Adam Kaplin, M.D., Ph.D.

Kaplin (Cerebrum June 2015)Adam Kaplin, M.D., Ph.D. is the chief psychiatric consultant to the Johns Hopkins Multiple Sclerosis and Transverse Myelitis centers and has a joint appointment as a clinician-researcher in the departments of psychiatry and neurology at Johns Hopkins, where his research focuses on immune-mediated mechanisms of depression and cognitive impairment in CNS autoimmune diseases. Kaplin is on the board of medical advisors to the Montel Williams MS Foundation, and a medical advisor to the Cody Unser First Step Foundation, the Transverse Myelitis Association, Johns Hopkins Project RESTORE, and Race to Erase MS (formerly the Nancy Davis Foundation for MS). He is the inventor and co-developer of Mood 24/7, a site that employs mood-tracking technology, and also the CEO and president of Altammune, a startup biotechnology company specializing in developing aggressive new therapies to put autoimmune diseases into long-term remission. Kaplin graduated from Yale University before receiving his M.D. and Ph.D. from the Johns Hopkins University School of Medicine.